These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18751564)

  • 1. Differential neurophysiological effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS) in non-human primates.
    Cycowicz YM; Luber B; Spellman T; Lisanby SH
    Clin EEG Neurosci; 2008 Jul; 39(3):144-9. PubMed ID: 18751564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in Seizure Expression Between Magnetic Seizure Therapy and Electroconvulsive Shock.
    Cycowicz YM; Rowny SB; Luber B; Lisanby SH
    J ECT; 2018 Jun; 34(2):95-103. PubMed ID: 29240021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurophysiological characterization of high-dose magnetic seizure therapy: comparisons with electroconvulsive shock and cognitive outcomes.
    Cycowicz YM; Luber B; Spellman T; Lisanby SH
    J ECT; 2009 Sep; 25(3):157-64. PubMed ID: 19300292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal electrically administered seizure therapy: a novel form of ECT illustrates the roles of current directionality, polarity, and electrode configuration in seizure induction.
    Spellman T; Peterchev AV; Lisanby SH
    Neuropsychopharmacology; 2009 Jul; 34(8):2002-10. PubMed ID: 19225453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential heart rate response to magnetic seizure therapy (MST) relative to electroconvulsive therapy: a nonhuman primate model.
    Rowny SB; Cycowicz YM; McClintock SM; Truesdale MD; Luber B; Lisanby SH
    Neuroimage; 2009 Sep; 47(3):1086-91. PubMed ID: 19497373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial of the cognitive side-effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS).
    Moscrip TD; Terrace HS; Sackeim HA; Lisanby SH
    Int J Neuropsychopharmacol; 2006 Feb; 9(1):1-11. PubMed ID: 16045810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of high-dose magnetic seizure therapy and electroconvulsive shock on cognitive function.
    Spellman T; McClintock SM; Terrace H; Luber B; Husain MM; Lisanby SH
    Biol Psychiatry; 2008 Jun; 63(12):1163-70. PubMed ID: 18262171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparable seizure characteristics in magnetic seizure therapy and electroconvulsive therapy for major depression.
    Kayser S; Bewernick BH; Hurlemann R; Soehle M; Schlaepfer TE
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1541-50. PubMed ID: 23820052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of ictal EEG in Magnetic Seizure Therapy at various stimulation frequencies.
    Backhouse FA; Noda Y; Knyahnytska Y; Farzan F; Downar J; Rajji TK; Mulsant BH; Daskalakis ZJ; Blumberger DM
    Clin Neurophysiol; 2018 Aug; 129(8):1770-1779. PubMed ID: 29735419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy.
    Lisanby SH; Luber B; Schlaepfer TE; Sackeim HA
    Neuropsychopharmacology; 2003 Oct; 28(10):1852-65. PubMed ID: 12865903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurophysiological characterization of magnetic seizure therapy (MST) in non-human primates.
    Lisanby SH; Moscrip T; Morales O; Luber B; Schroeder C; Sackeim HA
    Suppl Clin Neurophysiol; 2003; 56():81-99. PubMed ID: 14677385
    [No Abstract]   [Full Text] [Related]  

  • 12. Bilateral bispectral index monitoring during and after electroconvulsive therapy compared with magnetic seizure therapy for treatment-resistant depression.
    Soehle M; Kayser S; Ellerkmann RK; Schlaepfer TE
    Br J Anaesth; 2014 Apr; 112(4):695-702. PubMed ID: 24305645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualized Low-Amplitude Seizure Therapy: Minimizing Current for Electroconvulsive Therapy and Magnetic Seizure Therapy.
    Peterchev AV; Krystal AD; Rosa MA; Lisanby SH
    Neuropsychopharmacology; 2015 Aug; 40(9):2076-84. PubMed ID: 25920013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational development strategy for magnetic seizure therapy.
    Rowny SB; Benzl K; Lisanby SH
    Exp Neurol; 2009 Sep; 219(1):27-35. PubMed ID: 19348798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seizure expression during electroconvulsive therapy: relationships with clinical outcome and cognitive side effects.
    Perera TD; Luber B; Nobler MS; Prudic J; Anderson C; Sackeim HA
    Neuropsychopharmacology; 2004 Apr; 29(4):813-25. PubMed ID: 14735129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of the comparative efficacy of 100 Hz magnetic seizure therapy and electroconvulsive therapy in persistent depression.
    Fitzgerald PB; Hoy KE; Elliot D; McQueen S; Wambeek LE; Chen L; Clinton AM; Downey G; Daskalakis ZJ
    Depress Anxiety; 2018 May; 35(5):393-401. PubMed ID: 29329499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on magnetic seizure therapy: a novel form of convulsive therapy.
    Lisanby SH
    J ECT; 2002 Dec; 18(4):182-8. PubMed ID: 12468992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degree of Postictal Suppression Depends on Seizure Induction Time in Magnetic Seizure Therapy and Electroconvulsive Therapy.
    Kayser S; Bewernick BH; Soehle M; Switala C; Gippert SM; Dreimueller N; Schlaepfer TE
    J ECT; 2017 Sep; 33(3):167-175. PubMed ID: 28640168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectral EEG effects of electroconvulsive shock stimulus parameters: the development of a rationale for the optimization of the ECT stimulus.
    Sudha S; Andrade C; Mukundan CR; Chandra JS
    J ECT; 2003 Dec; 19(4):197-210. PubMed ID: 14657772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimum Electric Field Exposure for Seizure Induction with Electroconvulsive Therapy and Magnetic Seizure Therapy.
    Lee WH; Lisanby SH; Laine AF; Peterchev AV
    Neuropsychopharmacology; 2017 May; 42(6):1192-1200. PubMed ID: 27934961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.